test

Weston Nichols

@Lynx1 Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$282.238MTotal holdings18
Assets growth rate1.82%Assets growth rate (2-Q avg)-13.39%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Lynx1 Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 18 positions.

Assets under management

The assets under management (AUM) of Lynx1 Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 282.238M in assets, with a quarterly growth rate of 1.82% and a 2-quarter average growth rate of -13.39%. The portfolio is managed by Weston Nichols, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MRUSMerus N V
Recent Activity
Increased 48.66%
31.76%
$89.622M
1.794M shares@ $49.96 avg price
STOKStoke Therapeutics Inc
Recent Activity
Increased 0.04%
22.59%
$63.751M
5.187M shares@ $12.29 avg price
CCCCC4 Therapeutics Inc
Recent Activity
13.9%
$39.219M
6.881M shares@ $5.71 avg price
GHRSGh Research Plc
Recent Activity
Increased 5.78%
9.95%
$28.071M
4.196M shares@ $6.7 avg price
TCRXTscan Therapeutics Inc
Recent Activity
9.22%
$26.019M
5.225M shares@ $4.98 avg price
ALLOAllogene Therapeutics Inc
Recent Activity
Increased 178.35%
6.16%
$17.367M
6.202M shares@ $2.8 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
Increased 8.89%
2.44%
$6.877M
410,830 shares@ $16.74 avg price
PASGPassage Bio Inc
Recent Activity
Increased 66.62%
2.1%
$5.899M
8.427M shares@ $0.71 avg price
IBIOIbio Inc
Recent Activity
Increased 2.56%
0.68%
$1.914M
862,279 shares@ $2.22 avg price
CRBUCaribou Biosciences Inc
Recent Activity
New Position
0.48%
$1.333M
680,189 shares@ $1.96 avg price